全文获取类型
收费全文 | 1352541篇 |
免费 | 113024篇 |
国内免费 | 6539篇 |
专业分类
耳鼻咽喉 | 17075篇 |
儿科学 | 43254篇 |
妇产科学 | 36745篇 |
基础医学 | 185867篇 |
口腔科学 | 36500篇 |
临床医学 | 121746篇 |
内科学 | 281167篇 |
皮肤病学 | 32316篇 |
神经病学 | 111459篇 |
特种医学 | 56422篇 |
外国民族医学 | 274篇 |
外科学 | 212407篇 |
综合类 | 31622篇 |
现状与发展 | 3篇 |
一般理论 | 416篇 |
预防医学 | 107127篇 |
眼科学 | 28552篇 |
药学 | 94788篇 |
5篇 | |
中国医学 | 2391篇 |
肿瘤学 | 71968篇 |
出版年
2018年 | 13823篇 |
2017年 | 10941篇 |
2016年 | 13277篇 |
2015年 | 14994篇 |
2014年 | 20778篇 |
2013年 | 30654篇 |
2012年 | 37533篇 |
2011年 | 40052篇 |
2010年 | 25119篇 |
2009年 | 24474篇 |
2008年 | 37195篇 |
2007年 | 39578篇 |
2006年 | 40664篇 |
2005年 | 39125篇 |
2004年 | 37227篇 |
2003年 | 36260篇 |
2002年 | 34258篇 |
2001年 | 66249篇 |
2000年 | 68062篇 |
1999年 | 56701篇 |
1998年 | 16796篇 |
1997年 | 15079篇 |
1996年 | 16066篇 |
1995年 | 16276篇 |
1994年 | 15131篇 |
1993年 | 14183篇 |
1992年 | 47170篇 |
1991年 | 45812篇 |
1990年 | 44024篇 |
1989年 | 41870篇 |
1988年 | 38816篇 |
1987年 | 38155篇 |
1986年 | 35905篇 |
1985年 | 34682篇 |
1984年 | 26385篇 |
1983年 | 22133篇 |
1982年 | 13870篇 |
1981年 | 12463篇 |
1980年 | 11729篇 |
1979年 | 23556篇 |
1978年 | 17097篇 |
1977年 | 14391篇 |
1976年 | 13189篇 |
1975年 | 13727篇 |
1974年 | 16100篇 |
1973年 | 15400篇 |
1972年 | 14178篇 |
1971年 | 13043篇 |
1970年 | 11885篇 |
1969年 | 11104篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
P Toulon J F Vitoux J N Fiessinger D Sicard M Aiach 《Blood coagulation & fibrinolysis》1991,2(3):435-439
In human plasma, heparin cofactor II (HCII) is a thrombin inhibitor which displays similarities with antithrombin III (ATIII). As previously reported for hereditary ATIII deficiency, cases of recurrent thrombosis were reported in patients with hereditary HCII deficiency. Here, plasma HCII activity was studied in 372 patients with a history of thrombosis, classified according to their anticoagulant therapy. The mean plasma HCII level was significantly higher in patients with acute deep vein thrombosis (DVT) under heparin therapy than in patients with a history of thrombosis, who were studied more than 3 months after the acute event, and were either on, or had been on, oral anticoagulant therapy. HCII and fibrinogen were significantly correlated in all three groups of patients. These results were strengthened by those of a follow-up study in 23 patients with acute DVT. Changes in plasma HCII activity paralleled those of fibrinogen. This suggests that HCII might behave like an acute phase reactant in patients with thrombosis and that the measurement of its plasma level as a risk factor for thrombosis should be performed some time after the acute episode. In conclusion, the prevalence of HCII deficiency in patients with a history of thrombosis might have been underestimated in series which included patients with acute thrombosis. 相似文献
992.
J S Abramowicz S L Warsof D M Sherer D L Levy J R Woods 《Journal of ultrasound in medicine》1991,10(6):337-339
A prospective blinded study was performed on 191 high-risk patients with pregnancies ranging from 25 to 42 weeks gestation to investigate the value of a single Doppler analysis of the umbilical artery blood flow waveform (systolic-to-diastolic ratio, S/D) for predicting poor perinatal outcome. This was defined as the presence of heavy meconium, delivery of a growth-retarded infant, an umbilical cord arterial pH less than 7.2, or a 5-minute Apgar score less than 7. The interval between Doppler examination and delivery ranged from 12 hours to 15 weeks. No clinical data were available to the examiner performing the Doppler study. Moreover, the Doppler measurements were unknown to the attending physicians. The sensitivity, specificity, and positive and negative predictive values of the Doppler study in predicting outcome were 30.4%, 92.9%, 36.8%, and 92.6%, respectively, with an adverse outcome prevalence of 12%. These results indicate that a single random S/D ratio from the umbilical artery is not an adequate screening test for the risk of perinatal complications. 相似文献
993.
994.
Bruce D. Cheson 《Seminars in Oncology Nursing》1991,7(4):235-242
The National Cancer Institute (NCI) is the largest single sponsor of studies using anti-neoplastic agents with over 100 compounds currently in various stages of clinical testing. Most of the clinical trials are conducted by the NCI sponsored cooperative oncology groups and community oncology programs, cancer centers, and the pharmaceutical industry. These organizations conduct studies both independently as well as in a collaborative fashion. 相似文献
995.
ABSTRACT. A girl with phenylketonuria and mild mental retardation developed a behaviour disorder and anorexia nervosa at the age of 14. The anorexic symptoms disappeared at the age of 20, but the behaviour disorder worsened, leading to compulsory detention in a psychiatric hospital. Serum phenylalanine levels may have influenced the course of the disorder. 相似文献
996.
997.
998.
999.
Biopharmaceutic comparison is achieved between commercialized capsules of vinburnine and drops dosage form intended for geriatric pharmacotherapy. Drug bioavailability of vinburnine seems saved, if not significantly increased by the new formulation, in spite of the very important, and well known interindividual variations of vincamine drug products. Only the absorption rate seems statistically increased by drops. 相似文献
1000.
D Webber I P Braidman W R Robertson D C Anderson 《Journal of bone and mineral research》1989,4(6):809-815
Tartrate-resistant acid phosphatase activity (TRAPase) is widely used as a cytochemical marker to distinguish osteoclasts from macrophages and other related cell types. The degree of tartrate resistance, however, may depend on which reaction methods, tissues, or species are used. To investigate this further, we have measured the amount of cytochemical reaction product by microdensitometry. We compared osteoclast acid phosphatase (APase) activity in fresh frozen sections of neonatal rat calvaria using two different reaction methods; one is commonly employed for qualitative histochemistry and includes alpha naphthyl phosphate as substrate, simultaneous coupling to the chromagen Fast Garnet, and a 30-minute reaction time (method A). The other may be used to measure enzyme reaction rates in cells in situ and employs conditions suitable for initial velocity kinetics, namely naphthol-ASBI phosphate as substrate, post coupling to Fast Garnet, and a 2-minute reaction time. Although enzyme reaction rates differed greatly between the two methods, significant inhibition of APase activity by tartrate was observed in calvarial osteoclasts (69% and 59% with methods A and B, respectively), osteoblasts, and spleen macrophages. Using method B, mouse calvarial osteoclasts had similar APase activity to that seen in the rat. Tartrate produced little inhibition in these mouse cells, in contrast to the observations made with rat tissue, but murine spleen macrophages were significantly tartrate sensitive (40% inhibition with tartrate). On this basis, conclusions regarding the cell specificity of TRAPase should be treated cautiously. 相似文献